M3, Inc. Reports Consolidated Earnings Results for the Nine Months Ended December 31, 2020
January 29, 2021 at 01:00 am EST
Share
M3, Inc. reported consolidated earnings results for the nine months ended December 31, 2020. For the period, the company reported net sales of JPY 123,750 million against JPY 96,319 million a year ago. Operating profit was JPY 42,468 million against JPY 26,933 million a year ago. Net profit was JPY 29,507 million against JPY 18,616 million a year ago. Basic EPS was JPY 39.36 against 24.45 a year ago. Diluted EPS was JPY 39.32 against 24.44 a year ago.
M3, Inc. specializes in the provision of online services dedicated to the health field. Net sales (before intra-group eliminations) break down by activity as follows:
- medical marketing support services (40.3%): services enabling doctors and health professionals to search for medical resources, use the latest medical news, exchange opinions, learn about medical products and services and career development, etc. via m3.com., MR-kun, MDLinx and MEDI: GATE;
- support services to medical institutions (16.5%):
- clinical trial related services (10.7%): clinical trial support and clinical trial operations management services;
- human resources services (6.6%);
- other (1.6%): including marketing assistance and surveys of affiliated medical companies via specialized sites.
The balance of sales (24.3%) concerns international activities.
M3, INC. 
